City

Saint Paul (2)

Bethesda (1)

Doral (1)

Norfolk (1)

Condition

HSV (5)

Herpes Labialis (2)

CMV (1)

EBV (1)

HPV (1)

Hiv (1)

VZV (1)

Overall Status

Completed (2)

Available (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Squarex, LLC (2)

AiCuris Anti-infective Cures AG (1)

CONRAD (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Eastern Virginia Medical School (1)

Impatients N.V. trading as myTomorrows (1)

United States Agency for International Development (USAID) (1)

Intervention

squaric acid dibutyl ester (2)

pritelivir (1)

taf/evg vaginal insert (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (3)

NIH (1)

Other (1)

Study Type

Interventional (3)

Expanded Access (1)

Observational (1)

hsv

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HSV Trial (Pritelivir)

Available

HSV

Pritelivir

(no location specified)

Apr 25, 2023

Immune Defects in Patients Without Known Immunocompromise

Recruiting

EBV
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 11, 2023

HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)

Completed

HSV
Herpes Labialis

Squaric Acid Dibutyl Ester

Saint Paul, Minnesota

Prism Clinical Research, LLC

Oct 5, 2021

Herpes Labialis, HSV Trial in Doral, Saint Paul (Squaric Acid Dibutyl Ester)

Terminated

Herpes Labialis
HSV

Squaric Acid Dibutyl Ester

Doral, Florida
+1 more

Aug 4, 2021

Hiv, HSV Trial in Norfolk (TAF/EVG Vaginal Insert)

Completed

Hiv
HSV

TAF/EVG Vaginal Insert

Norfolk, Virginia

Clinical Research Center at Eastern Virginia Medical School (NOT

Jul 15, 2019